NASHVILLE, Tenn., Nov. 6, 2024 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") announced results for the quarter ended September 30, 2024.
HIGHLIGHTS
"At Brookdale, we are deeply committed to creating value for our shareholders by providing high-quality care and services to our residents, ensuring that we are an attractive place for employees to work, and improving both our capital structure and capital allocation," said Lucinda ("Cindy") Baier, Brookdale's President and CEO. "In the third quarter, this included not only our day-to-day operations, but also helping to ensure our residents' and associates' health and safety through multiple major hurricanes, being named a Most Loved Workplace by Newsweek, meaningfully growing Adjusted Free Cash Flow, more than doubling our number of Brookdale HealthPlus communities, and negotiating multiple accretive transactions that will benefit Brookdale and our shareholders in the immediate-term and over the long-term."
SUMMARY OF THIRD QUARTER FINANCIAL RESULTS
Consolidated summary of operating results and metrics:
Year-Over-Year Increase / | Sequential Increase / | |||||||
($ in millions, except RevPAR and RevPOR) | 3Q 2024 | 3Q 2023 | Amount | Percent | 2Q 2024 | Amount | Percent | |
Resident fees | $ 743.7 | $ 717.1 | $ 26.6 | 3.7 % | $ 739.7 | $ 4.0 | 0.5 % | |
Facility operating expense | 548.3 | 537.4 | 10.9 | 2.0 % | 537.5 | 10.8 | 2.0 % | |
Cash facility operating lease payments | 64.4 | 64.6 | (0.2) | (0.3) % | 64.4 | — | — % | |
Net income (loss) | (50.7) | (48.8) | 1.9 | 3.9 % | (37.7) | 13.0 | 34.4 % | |
Adjusted EBITDA (1) | 92.2 | 80.2 | 12.0 | 15.0 % | 97.8 | (5.6) | (5.7) % | |
RevPAR | $ 4,869 | $ 4,596 | $ 273 | 5.9 % | $ 4,835 | $ 34 | 0.7 % | |
Weighted average occupancy | 78.9 % | 77.6 % | 130 bps | n/a | 78.1 % | 80 bps | n/a | |
RevPOR | $ 6,171 | $ 5,919 | $ 252 | 4.3 % | $ 6,193 | $ (22) | (0.4) % |
(1) | Adjusted Free Cash Flow and Adjusted EBITDA are financial measures that are not calculated in accordance with GAAP. See "Non-GAAP Financial Measures" for the Company's definition of such measures, reconciliations to the most comparable GAAP financial measures, and other important information regarding the use of the Company's non-GAAP financial measures. |
Same community(2) summary of operating results and metrics:
Year-Over-Year Increase / | Sequential | |||||||
($ in millions, except RevPAR and RevPOR) | 3Q 2024 | 3Q 2023 | Amount | Percent | 2Q 2024 | Amount | Percent | |
Resident fees | $ 730.9 | $ 691.9 | $ 39.0 | 5.6 % | $ 725.9 | $ 5.0 | 0.7 % | |
Facility operating expense | $ 536.9 | $ 515.7 | $ 21.2 | 4.1 % | $ 527.1 | $ 9.8 | 1.9 % | |
RevPAR | $ 4,859 | $ 4,601 | $ 258 | 5.6 % | $ 4,826 | $ 33 | 0.7 % | |
Weighted average occupancy | 78.9 % | 77.9 % | 100 bps | n/a | 78.1 % | 80 bps | n/a | |
RevPOR | $ 6,155 | $ 5,909 | $ 246 | 4.2 % | $ 6,177 | $ (22) | (0.4) % |
(2) | The same community senior housing portfolio includes operating results and data for 611 communities consolidated and operational for the full period in both comparison years. Consolidated communities excluded from the same community portfolio include communities acquired or disposed of since the beginning of the prior year, communities classified as assets held for sale, certain communities planned for disposition, certain communities that have undergone or are undergoing expansion, redevelopment, and repositioning projects, and certain communities that have experienced a casualty event that significantly impacts their operations. To aid in comparability, same community operating results exclude natural disaster expense. |
Recent consolidated occupancy trend:
2023 | ||||||||||||
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
Weighted average | 76.6 % | 76.3 % | 76.1 % | 76.2 % | 76.6 % | 76.8 % | 77.1 % | 77.6 % | 78.2 % | 78.6 % | 78.4 % | 78.3 % |
Month end | 77.6 % | 77.4 % | 77.6 % | 77.6 % | 78.1 % | 78.2 % | 78.5 % | 79.3 % | 79.7 % | 79.5 % | 79.6 % | 79.3 % |
2024 | ||||||||||||
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | |||
Weighted average | 78.0 % | 77.9 % | 77.9 % | 77.9 % | 78.1 % | 78.2 % | 78.6 % | 78.9 % | 79.2 % | 79.4 % | ||
Month end | 79.3 % | 79.2 % | 79.1 % | 79.2 % | 79.5 % | 79.7 % | 79.9 % | 80.4 % | 80.5 % | 80.8 % |
OVERVIEW OF THIRD QUARTER RESULTS
LIQUIDITY
Year-Over-Year Increase / | Sequential Increase / | ||||
($ in millions) | 3Q 2024 | 3Q 2023 | Amount | 2Q 2024 | Amount |
Net cash provided by operating activities | $ 66.5 | $ 45.8 | $ 20.7 | $ 55.7 | $ 10.8 |
Non-development capital expenditures, net | 41.7 | 47.2 | (5.5) | 52.3 | (10.6) |
Adjusted Free Cash Flow | 13.9 | 2.5 | 11.4 | (5.5) | 19.4 |
TRANSACTION AND FINANCING UPDATE
Agreements to Acquire Currently Leased Assets
In September 2024, the Company entered into three definitive agreements to acquire 41 communities (2,789 units) that are currently leased by the Company for a combined purchase price of $610.0 million, as further described in the press release issued on September 30, 2024. These three transactions are expected to close by year-end, subject to the satisfaction of customary closing conditions for real estate transactions. The Company expects to fund these acquisitions through the assumption of existing mortgage debt, the net cash proceeds from the sale of the 3.50% convertible senior notes due 2029 (the "2029 New Notes"), proceeds from non-recourse mortgage financing on certain of the assets, and cash on hand. The Company expects these three transactions will result in an approximately $46.6 million decrease in cash paid for operating and financing leases for the twelve months ending December 31, 2025 compared to the previously required estimated 2025 lease payments and assuming the renewal of the lease for five of the communities at the end of its current term on December 31, 2024. The leases for 36 of the communities were previously classified as operating leases and have been prospectively classified as financing leases subsequent to the amendment of the leasing arrangements. The Company expects the amendment of the leasing arrangements will result in an approximately $8.1 million and $32.8 million decrease in cash paid for operating leases for the three months ending December 31, 2024 and the twelve months ending December 31, 2025, respectively, as a result of the reclassification of lease costs due to financing lease classification and the expected acquisition transactions.
Convertible Senior Notes
On September 30, 2024, the Company entered into privately negotiated agreements with certain of the holders of its outstanding 2.00% convertible senior notes due 2026 (the "2026 Notes") to exchange a portion of its existing 2026 Notes for a newly issued series of 2029 New Notes, as further described in the press release issued on September 30, 2024. On October 3, 2024, the Company issued $369.4 million aggregate principal amount of its 2029 New Notes. At closing, $219.4 million principal amount of the 2029 New Notes were issued in exchange for $206.7 million principal amount of the 2026 Notes and $150.0 million principal amount of the 2029 New Notes were issued for cash. The Company's net cash proceeds from the exchange and issuance transactions, after subtracting fees, discounts and estimated expenses payable by the Company, were approximately $135.0 million. Following the closing, $23.3 million in aggregate principal amount of the 2026 Notes remain outstanding with the terms unchanged.
Omega Lease Amendment
In August 2024, the Company and Omega Healthcare Investors, Inc. ("Omega") amended the existing master lease pursuant to which the Company continues to lease 24 communities (2,555 units) from Omega. The Company's amended master lease has an initial term to expire on December 31, 2037. As part of the amendment, Omega agreed to make available up to $80.0 million to fund costs associated with capital expenditures for the communities through December 31, 2037. The annual rent under the lease will not be adjusted upon reimbursements for capital expenditures in the aggregate amount of up to $30.0 million of the $80.0 million pool, which is available in certain tranches through June 30, 2028. With respect to the remaining $50.0 million of the $80.0 million pool, the annual rent under the lease will prospectively increase by the amount of each reimbursement multiplied by 9.5%. The $50.0 million will be available in certain tranches beginning January 1, 2025, subject to certain annual reimbursement caps specified in the lease. Under the terms of the amendment, rent will escalate annually per the terms of the existing lease escalator, with a potential minor contingent rent adjustment beginning in 2028 depending on lease performance.
Mortgage Debt Financing
In September 2024, the Company obtained $182.5 million of debt secured by first priority mortgages on 16 communities. The loan bears interest at a fixed rate of 5.67% and is interest only for the first two years. The debt matures in October 2029. At the closing, the Company repaid $197.1 million of outstanding mortgage debt, which was scheduled to mature in September 2025, using proceeds from the $182.5 million debt and cash on hand. The closing of this transaction results in no remaining debt maturities without extension options through June 2026.
2024 OUTLOOK
For the fourth quarter 2024, the Company is providing the following guidance:
Fourth Quarter 2024 Guidance | |
RevPAR year-over-year growth | 5.0% to 5.5% |
Adjusted EBITDA | $93 million to $98 million |
The Company expects its fourth quarter 2024 cash facility operating lease payments to be approximately $56.0 million, after giving effect to the change in lease classification for communities subject to acquisition agreements.
In the aggregate, the Company expects its full-year 2024 non-development capital expenditures, net of anticipated lessor reimbursements and property and casualty insurance proceeds, to be approximately $180.0 million.
This guidance excludes future acquisition or disposition activity. Reconciliation of the non-GAAP financial measure included in the foregoing guidance to the most comparable GAAP financial measure is not available without unreasonable effort due to the inherent difficulty in forecasting the timing or amounts of items required to reconcile Adjusted EBITDA from the Company's net income (loss). Variability in the timing or amounts of items required to reconcile the measure may have a significant impact on the Company's future GAAP results.
SUPPLEMENTAL INFORMATION
The Company will post on its website at brookdaleinvestors.com supplemental information relating to the Company's third quarter results, an updated investor presentation, and a copy of this earnings release. The supplemental information and a copy of this earnings release will also be furnished in a Form 8-K to be filed with the SEC.
EARNINGS CONFERENCE CALL
Brookdale's management will conduct a conference call to discuss the financial results for the third quarter on November 7, 2024 at 9:00 AM ET. The conference call can be accessed by dialing (800) 715-9871 (from within the U.S.) or (646) 307-1963 (from outside of the U.S.) ten minutes prior to the scheduled start and referencing the access code "1482282".
A webcast of the conference call will be available to the public on a listen-only basis at brookdaleinvestors.com. Please allow extra time before the call to download the necessary software required to listen to the internet broadcast. A replay of the webcast will be available through the website following the call.
For those who cannot listen to the live call, a replay of the webcast will be available until 11:59 PM ET on November 14, 2024 by dialing (800) 770-2030 (from within the U.S.) or (647) 362-9199 (from outside of the U.S.) and referencing access code "1482282#".
ABOUT BROOKDALE SENIOR LIVING
Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. The Company is committed to its mission of enriching the lives of the people it serves with compassion, respect, excellence, and integrity. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities. Through its comprehensive network, Brookdale helps to provide seniors with care, connection, and services in an environment that feels like home. The Company's expertise in healthcare, hospitality, and real estate provides residents with opportunities to improve wellness, pursue passions, make new friends, and stay connected with loved ones. Brookdale, through its affiliates, operates and manages 648 communities in 41 states as of September 30, 2024, with the ability to serve approximately 58,000 residents. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.
DEFINITIONS OF REVPAR AND REVPOR
RevPAR, or average monthly senior housing resident fee revenue per available unit, is defined by the Company as resident fee revenue for the corresponding portfolio for the period (excluding revenue for private duty services provided to seniors living outside of the Company's communities and entrance fee amortization), divided by the weighted average number of available units in the corresponding portfolio for the period, divided by the number of months in the period.
RevPOR, or average monthly senior housing resident fee revenue per occupied unit, is defined by the Company as resident fee revenue for the corresponding portfolio for the period (excluding revenue for private duty services provided to seniors living outside of the Company's communities and entrance fee amortization), divided by the weighted average number of occupied units in the corresponding portfolio for the period, divided by the number of months in the period.
SAFE HARBOR
Certain statements in this press release and the associated earnings call may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical statements of fact and those regarding the Company's intent, belief, or expectations. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "may," "will," "should," "could," "would," "potential," "intend," "expect," "endeavor," "seek," "anticipate," "estimate," "believe," "project," "predict," "continue," "plan," "target," or other similar words or expressions, and include statements regarding the Company's expected financial and operational results. These forward-looking statements are based on certain assumptions and expectations, and the Company's ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Although the Company believes that expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that its assumptions or expectations will be attained and actual results and performance could differ materially from those projected. Factors which could have a material adverse effect on the Company's operations and future prospects or which could cause events or circumstances to differ from the forward-looking statements include, but are not limited to, events which adversely affect the ability of seniors to afford resident fees, including downturns in the economy, housing market, consumer confidence, or the equity markets and unemployment among resident family members; changes in reimbursement rates, methods, or timing under governmental reimbursement programs including the Medicare and Medicaid programs; the effects of senior housing construction and development, lower industry occupancy, and increased competition; conditions of housing markets, regulatory changes, acts of nature, and the effects of climate change in geographic areas where the Company is concentrated; terminations of the Company's resident agreements and vacancies in the living spaces it leases; failure to maintain the security and functionality of the Company's information systems, to prevent a cybersecurity attack or breach, or to comply with applicable privacy and consumer protection laws, including HIPAA; the Company's ability to complete its capital expenditures in accordance with its plans; the Company's ability to identify and pursue development, investment, and acquisition opportunities and its ability to successfully integrate acquisitions; competition for the acquisition of assets; the Company's ability to complete pending or expected disposition, acquisition, or other transactions on agreed upon terms or at all, including in respect of the satisfaction of closing conditions, the risk that regulatory approvals are not obtained or are subject to unanticipated conditions, and uncertainties as to the timing of closing, and the Company's ability to identify and pursue any such opportunities in the future; risks related to the implementation of the Company's strategy, including initiatives undertaken to execute on the Company's strategic priorities and their effect on its results; the impacts of the COVID-19 pandemic, including on the nation's economy and debt and equity markets and the local economies in our markets, and on us and our business, results of operations, cash flow, revenue, expenses, liquidity, and our strategic initiatives, including plans for future growth, which will depend on many factors, some of which cannot be foreseen, including the pace and consistency of recovery from the pandemic and any resurgence or variants of the disease; limits on the Company's ability to use net operating loss carryovers to reduce future tax payments; delays in obtaining regulatory approvals; disruptions in the financial markets or decreases in the appraised values or performance of the Company's communities that affect the Company's ability to obtain financing or extend or refinance debt as it matures and the Company's financing costs; the Company's ability to generate sufficient cash flow to cover required interest, principal, and long-term lease payments and to fund its planned capital projects; the effect of any non-compliance with any of the Company's debt or lease agreements (including the financial or other covenants contained therein), including the risk of lenders or lessors declaring a cross default in the event of the Company's non-compliance with any such agreements and the risk of loss of the Company's property securing leases and indebtedness due to any resulting lease terminations and foreclosure actions; the inability to renew, restructure, or extend leases, or exercise purchase options at or prior to the end of any existing lease term; the effect of the Company's indebtedness and long-term leases on the Company's liquidity and its ability to operate its business; increases in market interest rates that increase the costs of the Company's debt obligations; the Company's ability to obtain additional capital on terms acceptable to it; departures of key officers and potential disruption caused by changes in management; increased competition for, or a shortage of, associates (including due to general labor market conditions), wage pressures resulting from increased competition, low unemployment levels, minimum wage increases and changes in overtime laws, and union activity; environmental contamination at any of the Company's communities; failure to comply with existing environmental laws; an adverse determination or resolution of complaints filed against the Company, including putative class action complaints, and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or the Company's response efforts; negative publicity with respect to any lawsuits, claims, or other legal or regulatory proceedings; costs to respond to, and adverse determinations resulting from, government inquiries, reviews, audits, and investigations; the cost and difficulty of complying with increasing and evolving regulation, including new disclosure obligations; changes in, or its failure to comply with, employment-related laws and regulations; the risks associated with current global economic conditions and general economic factors on the Company and the Company's business partners such as inflation, commodity costs, fuel and other energy costs, competition in the labor market, costs of salaries, wages, benefits, and insurance, interest rates, tax rates, geopolitical tensions or conflicts, and uncertainty surrounding federal elections; the impact of seasonal contagious illness or an outbreak of COVID-19 or other contagious disease in the markets in which the Company operates; actions of activist stockholders, including a proxy contest; as well as other risks detailed from time to time in the Company's filings with the Securities and Exchange Commission, including those set forth in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in such SEC filings. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect management's views as of the date of this press release and/or associated earnings call. The Company cannot guarantee future results, levels of activity, performance or achievements, and, except as required by law, it expressly disclaims any obligation to release publicly any updates or revisions to any forward-looking statements contained in this press release and/or associated earnings call to reflect any change in the Company's expectations with regard thereto or change in events, conditions, or circumstances on which any statement is based.
Condensed Consolidated Statements of Operations | |||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||
(in thousands, except per share data) | 2024 | 2023 | 2024 | 2023 | |||
Resident fees | $ 743,729 | $ 717,123 | $ 2,227,679 | $ 2,140,688 | |||
Management fees | 2,676 | 2,566 | 7,910 | 7,653 | |||
Reimbursed costs incurred on behalf of managed communities | 37,762 | 34,979 | 108,950 | 103,932 | |||
Other operating income | — | 2,623 | — | 9,073 | |||
Total revenue and other operating income | 784,167 | 757,291 | 2,344,539 | 2,261,346 | |||
Facility operating expense (excluding facility depreciation and | 548,282 | 537,411 | 1,628,339 | 1,599,336 | |||
General and administrative expense (including non-cash stock- | 44,929 | 43,076 | 137,325 | 137,021 | |||
Facility operating lease expense | 51,937 | 53,145 | 154,397 | 149,784 | |||
Depreciation and amortization | 90,064 | 85,932 | 264,219 | 255,314 | |||
Asset impairment | 934 | 9,086 | 2,642 | 9,606 | |||
Loss (gain) on sale of communities, net | — | — | — | (36,296) | |||
Costs incurred on behalf of managed communities | 37,762 | 34,979 | 108,950 | 103,932 | |||
Income (loss) from operations | 10,259 | (6,338) | 48,667 | 42,649 | |||
Interest income | 4,663 | 6,323 | 14,155 | 17,764 | |||
Interest expense: | |||||||
Debt | (54,171) | (53,413) | (161,405) | (155,984) | |||
Financing lease obligations | (5,062) | (4,950) | (15,233) | (16,955) | |||
Amortization of deferred financing costs | (2,337) | (1,910) | (6,928) | (5,749) | |||
Change in fair value of derivatives | (4,746) | 861 | (2,004) | 5,130 | |||
Gain (loss) on debt modification and extinguishment, net | (2,267) | — | (2,267) | — | |||
Equity in earnings (loss) of unconsolidated ventures | — | (1,426) | — | (3,156) | |||
Non-operating gain (loss) on sale of assets, net | 20 | — | 923 | 860 | |||
Other non-operating income (loss) | 3,584 | 10,166 | 7,121 | 16,512 | |||
Income (loss) before income taxes | (50,057) | (50,687) | (116,971) | (98,929) | |||
Benefit (provision) for income taxes | (677) | 1,876 | (1,086) | 1,029 | |||
Net income (loss) | (50,734) | (48,811) | (118,057) | (97,900) | |||
Net (income) loss attributable to noncontrolling interest | 14 | 15 | 44 | 45 | |||
Net income (loss) attributable to Brookdale Senior Living Inc. | $ (50,720) | $ (48,796) | $ (118,013) | $ (97,855) | |||
Basic and diluted net income (loss) per share attributable to | $ (0.22) | $ (0.22) | $ (0.52) | $ (0.43) | |||
Weighted average shares used in computing basic and diluted | 228,124 | 225,416 | 226,939 | 225,136 |
Condensed Consolidated Balance Sheets | |||
(in thousands) | September 30, 2024 | December 31, 2023 | |
Cash and cash equivalents | $ 254,711 | $ 277,971 | |
Marketable securities | 29,701 | 29,755 | |
Restricted cash | 49,067 | 41,341 | |
Accounts receivable, net | 53,002 | 48,393 | |
Prepaid expenses and other current assets, net | 87,236 | 80,908 | |
Total current assets | 473,717 | 478,368 | |
Property, plant and equipment and leasehold intangibles, net | 4,641,255 | 4,330,629 | |
Operating lease right-of-use assets | 732,918 | 670,907 | |
Other assets, net | 91,233 | 93,531 | |
Total assets | $ 5,939,123 | $ 5,573,435 | |
Current portion of long-term debt | $ 51,525 | $ 41,463 | |
Current portion of financing lease obligations | 1,160 | 1,075 | |
Current portion of operating lease obligations | 150,790 | 192,631 | |
Other current liabilities | 380,509 | 364,947 | |
Total current liabilities | 583,984 | 600,116 | |
Long-term debt, less current portion | 3,654,497 | 3,655,850 | |
Financing lease obligations, less current portion | 602,789 | 150,774 | |
Operating lease obligations, less current portion | 730,402 | 683,876 | |
Other liabilities | 73,129 | 77,666 | |
Total liabilities | 5,644,801 | 5,168,282 | |
Total Brookdale Senior Living Inc. stockholders' equity | 292,877 | 403,664 | |
Noncontrolling interest | 1,445 | 1,489 | |
Total equity | 294,322 | 405,153 | |
Total liabilities and equity | $ 5,939,123 | $ 5,573,435 |
Condensed Consolidated Statements of Cash Flows | |||
Nine Months Ended September 30, | |||
(in thousands) | 2024 | 2023 | |
Cash Flows from Operating Activities | |||
Net income (loss) | $ (118,057) | $ (97,900) | |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating | |||
Loss (gain) on debt modification and extinguishment, net | 2,267 | — | |
Depreciation and amortization, net | 271,147 | 261,063 | |
Asset impairment | 2,642 | 9,606 | |
Equity in (earnings) loss of unconsolidated ventures | — | 3,156 | |
Distributions from unconsolidated ventures from cumulative share of net earnings | — | 430 | |
Amortization of entrance fees | — | (732) | |
Proceeds from deferred entrance fee revenue | — | 477 | |
Deferred income tax (benefit) provision | (48) | (2,015) | |
Operating lease expense adjustment | (39,061) | (33,820) | |
Change in fair value of derivatives | 2,004 | (5,130) | |
Loss (gain) on sale of assets, net | (923) | (37,156) | |
Non-cash stock-based compensation expense | 10,651 | 8,966 | |
Property and casualty insurance income | (6,281) | (14,047) | |
Other non-operating (income) loss | — | (2,542) | |
Changes in operating assets and liabilities: | |||
Accounts receivable, net | (4,610) | 8,250 | |
Prepaid expenses and other assets, net | (6,414) | 9,347 | |
Prepaid insurance premiums financed with notes payable | (7,930) | (6,530) | |
Trade accounts payable and accrued expenses | 5,071 | 21,444 | |
Refundable fees and deferred revenue | 2,789 | 8,518 | |
Operating lease assets and liabilities for lessor capital expenditure reimbursements | 7,732 | 2,244 | |
Net cash provided by (used in) operating activities | 120,979 | 133,629 | |
Cash Flows from Investing Activities | |||
Purchase of marketable securities | (39,191) | (159,811) | |
Sale and maturities of marketable securities | 40,000 | 145,100 | |
Capital expenditures, net of related payables | (150,938) | (174,700) | |
Acquisition of assets, net of cash acquired | — | (574) | |
Investment in unconsolidated ventures | — | (7,589) | |
Proceeds from sale of assets, net | 7,017 | 43,181 | |
Property and casualty insurance proceeds | 6,297 | 19,536 | |
Change in lease acquisition deposits, net | (2,000) | — | |
Purchase of interest rate cap instruments | (9,282) | (7,223) | |
Proceeds from interest rate cap instruments | 14,816 | 6,501 | |
Other | (235) | (168) | |
Net cash provided by (used in) investing activities | (133,516) | (135,747) | |
Cash Flows from Financing Activities | |||
Proceeds from debt | 264,038 | 25,532 | |
Repayment of debt and financing lease obligations | (259,390) | (91,866) | |
Payment of financing costs, net of related payables | (6,309) | (940) | |
Payments of employee taxes for withheld shares | (3,425) | (1,880) | |
Net cash provided by (used in) financing activities | (5,086) | (69,154) | |
Net increase (decrease) in cash, cash equivalents, and restricted cash | (17,623) | (71,272) | |
Cash, cash equivalents, and restricted cash at beginning of period | 349,668 | 474,548 | |
Cash, cash equivalents, and restricted cash at end of period | $ 332,045 | $ 403,276 |
Non-GAAP Financial Measures
This earnings release contains the financial measures Adjusted EBITDA and Adjusted Free Cash Flow, which are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). Presentations of these non-GAAP financial measures are intended to aid investors in better understanding the factors and trends affecting the Company's performance and liquidity. However, investors should not consider these non-GAAP financial measures as a substitute for financial measures determined in accordance with GAAP, including net income (loss), income (loss) from operations, or net cash provided by (used in) operating activities. The Company cautions investors that amounts presented in accordance with the Company's definitions of these non-GAAP financial measures may not be comparable to similar measures disclosed by other companies because not all companies calculate non-GAAP measures in the same manner. The Company urges investors to review the following reconciliations of these non-GAAP financial measures from the most comparable financial measures determined in accordance with GAAP.
Adjusted EBITDA
Adjusted EBITDA is a non-GAAP performance measure that the Company defines as net income (loss) excluding: benefit/provision for income taxes, non-operating income/expense items, and depreciation and amortization; and further adjusted to exclude income/expense associated with non-cash, non-operational, transactional, cost reduction, or organizational restructuring items that management does not consider as part of the Company's underlying core operating performance and that management believes impact the comparability of performance between periods. For the periods presented herein, such other items include non-cash impairment charges, operating lease expense adjustment, non-cash stock-based compensation expense, and transaction and organizational restructuring costs. Transaction costs include those directly related to acquisition, disposition, financing, and leasing activity, and are primarily comprised of legal, finance, consulting, professional fees, and other third-party costs. Organizational restructuring costs include those related to the Company's efforts to reduce general and administrative expense and its senior leadership changes, including severance.
The Company believes that presentation of Adjusted EBITDA as a performance measure is useful to investors because (i) it is one of the metrics used by the Company's management for budgeting and other planning purposes, to review the Company's historic and prospective core operating performance, and to make day-to-day operating decisions; (ii) it provides an assessment of operational factors that management can impact in the short-term, namely revenues and the controllable cost structure of the organization, by eliminating items related to the Company's financing and capital structure and other items that management does not consider as part of the Company's underlying core operating performance and that management believes impact the comparability of performance between periods; (iii) the Company believes that this measure is used by research analysts and investors to evaluate the Company's operating results and to value companies in its industry; and (iv) the Company uses the measure for components of executive compensation.
Adjusted EBITDA has material limitations as a performance measure, including: (i) excluded interest and income tax are necessary to operate the Company's business under its current financing and capital structure; (ii) excluded depreciation, amortization, and impairment charges may represent the wear and tear and/or reduction in value of the Company's communities, goodwill, and other assets and may be indicative of future needs for capital expenditures; and (iii) the Company may incur income/expense similar to those for which adjustments are made, such as gain/loss on sale of assets, facility operating lease termination, or debt modification and extinguishment, non-cash stock-based compensation expense, and transaction and other costs, and such income/expense may significantly affect the Company's operating results.
The table below reconciles Adjusted EBITDA from net income (loss).
Three Months Ended | |||||
(in thousands) | September 30, 2024 | June 30, 2024 | September 30, 2023 | ||
Net income (loss) | $ (50,734) | $ (37,742) | $ (48,811) | ||
Provision (benefit) for income taxes | 677 | 449 | (1,876) | ||
Equity in (earnings) loss of unconsolidated ventures | — | — | 1,426 | ||
Loss (gain) on debt modification and extinguishment, | 2,267 | — | — | ||
Non-operating loss (gain) on sale of assets, net | (20) | (199) | — | ||
Other non-operating (income) loss | (3,584) | (199) | (10,166) | ||
Interest expense | 66,316 | 61,567 | 59,412 | ||
Interest income | (4,663) | (4,714) | (6,323) | ||
Income (loss) from operations | 10,259 | 19,162 | (6,338) | ||
Depreciation and amortization | 90,064 | 88,028 | 85,932 | ||
Asset impairment | 934 | — | 9,086 | ||
Operating lease expense adjustment | (12,489) | (13,483) | (11,458) | ||
Non-cash stock-based compensation expense | 3,403 | 3,975 | 2,893 | ||
Transaction and organizational restructuring costs | 66 | 134 | 105 | ||
Adjusted EBITDA | $ 92,237 | $ 97,816 | $ 80,220 |
Adjusted Free Cash Flow
Adjusted Free Cash Flow is a non-GAAP liquidity measure that the Company defines as net cash provided by (used in) operating activities before: distributions from unconsolidated ventures from cumulative share of net earnings, changes in prepaid insurance premiums financed with notes payable, changes in operating lease assets and liabilities for lease termination, cash paid/received for gain/loss on facility operating lease termination, and lessor capital expenditure reimbursements under operating leases; plus: property and casualty insurance proceeds and proceeds from refundable entrance fees, net of refunds; less: non-development capital expenditures and payment of financing lease obligations. Non-development capital expenditures are comprised of corporate and community-level capital expenditures, including those related to maintenance, renovations, upgrades, and other major building infrastructure projects for the Company's communities and is presented net of lessor reimbursements. Non-development capital expenditures do not include capital expenditures for: community expansions, major community redevelopment and repositioning projects, and the development of new communities.
The Company believes that presentation of Adjusted Free Cash Flow as a liquidity measure is useful to investors because (i) it is one of the metrics used by the Company's management for budgeting and other planning purposes, to review the Company's historic and prospective sources of operating liquidity, and to review the Company's ability to service its outstanding indebtedness, pay dividends to stockholders, engage in share repurchases, and make capital expenditures, including development capital expenditures; and (ii) it provides an indicator to management to determine if adjustments to current spending decisions are needed.
Adjusted Free Cash Flow has material limitations as a liquidity measure, including: (i) it does not represent cash available for dividends, share repurchases, or discretionary expenditures since certain non-discretionary expenditures, including mandatory debt principal payments, are not reflected in this measure; (ii) the cash portion of non-recurring charges related to gain/loss on facility lease termination generally represent charges/gains that may significantly affect the Company's liquidity; and (iii) the impact of timing of cash expenditures, including the timing of non-development capital expenditures, limits the usefulness of the measure for short-term comparisons.
The table below reconciles Adjusted Free Cash Flow from net cash provided by (used in) operating activities.
Three Months Ended | |||||
(in thousands) | September 30, 2024 | June 30, 2024 | September 30, 2023 | ||
Net cash provided by (used in) operating activities | $ 66,455 | $ 55,670 | $ 45,763 | ||
Net cash provided by (used in) investing activities | (58,113) | (68,457) | (31,837) | ||
Net cash provided by (used in) financing activities | (38,801) | (20,375) | (19,232) | ||
Net increase (decrease) in cash, cash equivalents, and restricted cash | $ (30,459) | $ (33,162) | $ (5,306) | ||
Net cash provided by (used in) operating activities | $ 66,455 | $ 55,670 | $ 45,763 | ||
Changes in prepaid insurance premiums financed with | (7,772) | (7,617) | (6,474) | ||
Changes in assets and liabilities for lessor capital | (6,432) | (1,051) | — | ||
Non-development capital expenditures, net | (41,718) | (52,325) | (47,248) | ||
Property and casualty insurance proceeds | 3,593 | 62 | 10,747 | ||
Payment of financing lease obligations | (273) | (265) | (244) | ||
Adjusted Free Cash Flow | $ 13,853 | $ (5,526) | $ 2,544 |
Last Trade: | US$5.07 |
Daily Change: | -0.04 -0.78 |
Daily Volume: | 283,882 |
Market Cap: | US$1.010B |
December 09, 2024 November 11, 2024 September 30, 2024 September 10, 2024 August 08, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB